theophylline and ranitidine

theophylline has been researched along with ranitidine in 63 studies

Research

Studies (63)

Timeframe	Studies, this research(%)	All Research%
pre-1990	22 (34.92)	18.7374
1990's	14 (22.22)	18.2507
2000's	13 (20.63)	29.6817
2010's	14 (22.22)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R	1
Lombardo, F; Obach, RS; Waters, NJ	1
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W	1
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Akamatsu, M	1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Chreifi, G; Do, HT; Li, H; Poulos, TL; Silverman, RB; Wang, HY	1
Bachmann, K; Jauregui, L; Levine, L; Martin, M; Mauro, LS; Sullivan, TJ	1
Klotz, U; Kroemer, HK	1
Betlach, CJ; Bialer, M; González, MA; Liebermann, P; Meyer, MC; Straughn, AB; Vashi, VI	1
Barkworth, MF; Blackshaw, PE; Greaves, JL; Perkins, AC; Rehm, KD; Washington, N; Wilson, CG	2
Bojović, I; Bozović, M; Despotović, N; Dmitrović, V; Milovanović, M; Paranos, S; Vidanović, M	1
Gilbert, RP; Hegman, GW	1
Boehning, W	1
Kelly, HW	1
Dal Negro, R; Pomart, C; Trevisan, F; Turco, P; Zoccatelli, O	1
Blaschke, TF; Lenert, L; Skinner, MH	1
Roy, AK	1
Colas des Francs, V; Dietemann-Molard, A; Oswald-Mammosser, M; Pauli, G; Popin, E	1
Cuda, MP; Levine, RA; Roy, AK	1
Ciancio, SG	1
Cordaro, CI; Dal Negro, R; De Conti, F; Pomari, C; Trevisan, F; Turco, P	1
Donohue, JF; Kelly, HW; Powell, JR	1
Bottino, G; Gianotti, A	1
Amitai, Y; Lovejoy, FH; Moye, J; Yeung, AC	1
Barzilay, M; Schey, G; Seggev, JS	1
Hussain, AS; Lücker, PW; Ritschel, WA; Wetzelsberger, N	1
Gardner, ME; Sikorski, GW	1
Frank, WO; Myerson, RM; Seaman, JJ	1
Breen, KJ; Bury, R; Desmond, PV; Mashford, ML; Morphett, B; Shaw, RG; Westwood, B	1
Ruff, F	1
Fernandes, E; Melewicz, FM	2
Cross, RE; Eshelman, FN; Powell, JR; Rogers, JF; Wargin, WA	1
Dobbs, JH; Smith, RN	1
Carloni, C; Dal Negro, R; Pomari, C; Trevisan, F; Turco, P; Zoccatelli, O	1
Huertas González, JM; Morata García de la Puerta, IJ; Pérez-Blanco, FJ; Saucedo Sánchez, R	1
Bachmann, KA; Jauregui, L; Levine, L; Miller, K; Reese, J; Sullivan, TJ	1
Cukier, A; Donzella, H; Light, RW; Santos, SR; Teixeira, LR; Terra-Filho, M; Vargas, FS	1
Harralson, AF; Jones, DW; Kehoe, WA; Lan, HH; Long, LF; Sands, CD; Shin, HT	1
Fitzgerald, K; Koch, KM; Mills, JG; Sirgo, MA; Webster, C; Wood, JR	1
Langkilde, FW; Taylor, LS	1
Budha, NR; Christensen, ML; Mehrotra, N; Meibohm, B; Zhang, Y	1
Bithell, EG; Eddleston, MD; Jones, W	1
Dahlgren, D; Lennernäs, H; Roos, C; Sjögren, E	1

Reviews

4 review(s) available for theophylline and ranitidine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
The drug interaction potential of ranitidine: an update. Pharmacology & therapeutics, 1991, Volume: 50, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiotonic Agents; Cyclosporine; Drug Interactions; Humans; Psychotropic Drugs; Ranitidine; Theophylline	1991
Ranitidine-theophylline interaction--fact or fiction? DICP : the annals of pharmacotherapy, 1991, Volume: 25, Issue:1 Topics: Delayed-Action Preparations; Drug Interactions; Female; Humans; Male; Middle Aged; Ranitidine; Theophylline	1991
The safety of ranitidine in over a decade of use. Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:1 Topics: Anti-Ulcer Agents; Clinical Trials as Topic; Databases, Factual; Drug Interactions; Ethanol; Heartburn; Histamine H2 Antagonists; Humans; Product Surveillance, Postmarketing; Ranitidine; Theophylline; Triazolam; Warfarin	1997

Trials

7 trial(s) available for theophylline and ranitidine

Article	Year
The effect of raising gastric pH with ranitidine on the absorption and elimination of theophylline from a sustained-release theophylline tablet. Pharmaceutical research, 1991, Volume: 8, Issue:12 Topics: Adult; Delayed-Action Preparations; Gastric Acid; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Male; Ranitidine; Stomach; Theophylline	1991
Effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained release theophylline preparation. Arzneimittel-Forschung, 1991, Volume: 41, Issue:11 Topics: Adult; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Double-Blind Method; Gastric Acidity Determination; Gastrointestinal Transit; Humans; Hydrogen-Ion Concentration; Indium Radioisotopes; Male; Ranitidine; Spectrophotometry, Ultraviolet; Theophylline	1991
Effect of cimetidine and ranitidine on plasma theophylline in patients with chronic obstructive airways disease treated with theophylline and corticosteroids. European journal of clinical pharmacology, 1990, Volume: 38, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cimetidine; Delayed-Action Preparations; Drug Interactions; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Random Allocation; Ranitidine; Theophylline; Time Factors	1990
H2-antagonist derangement of the kinetics of sustained-release oral theophylline. International journal of clinical pharmacology, therapy, and toxicology, 1985, Volume: 23, Issue:6 Topics: Delayed-Action Preparations; Forced Expiratory Volume; Histamine H2 Antagonists; Humans; Kinetics; Ranitidine; Theophylline	1985
[Interaction between ranitidine and theophylline]. Revista clinica espanola, 1995, Volume: 195, Issue:5 Topics: Adult; Aged; Double-Blind Method; Drug Interactions; Female; Humans; Male; Middle Aged; Ranitidine; Theophylline	1995
Effect of ranitidine on theophylline metabolism in healthy Koreans living in China. The Annals of pharmacotherapy, 1996, Volume: 30, Issue:2 Topics: Adolescent; Adult; Biotransformation; Bronchodilator Agents; China; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Drug Interactions; Histamine H2 Antagonists; Humans; Korea; Middle Aged; Ranitidine; Theophylline	1996
[The effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained-release theophylline preparation]. Arzneimittel-Forschung, 1998, Volume: 48, Issue:5A Topics: Adult; Anti-Asthmatic Agents; Capsules; Delayed-Action Preparations; Gastric Acid; Gastrointestinal Transit; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Ranitidine; Theophylline	1998

Other Studies

52 other study(ies) available for theophylline and ranitidine

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
QSAR study on permeability of hydrophobic compounds with artificial membranes. Bioorganic & medicinal chemistry, 2007, Jun-01, Volume: 15, Issue:11 Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
First-principle, structure-based prediction of hepatic metabolic clearance values in human. European journal of medicinal chemistry, 2009, Volume: 44, Issue:4 Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software	2009
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data. European journal of medicinal chemistry, 2009, Volume: 44, Issue:11 Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution	2009
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain. Bioorganic & medicinal chemistry, 2009, Oct-01, Volume: 17, Issue:19 Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Importance of physicochemical properties for the design of new pesticides. Journal of agricultural and food chemistry, 2011, Apr-13, Volume: 59, Issue:7 Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic	2011
QSAR-based permeability model for drug-like compounds. Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8 Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2011
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
Improvement of Cell Permeability of Human Neuronal Nitric Oxide Synthase Inhibitors Using Potent and Selective 2-Aminopyridine-Based Scaffolds with a Fluorobenzene Linker. Journal of medicinal chemistry, 2017, 11-22, Volume: 60, Issue:22 Topics: Aminopyridines; Animals; Blood-Brain Barrier; Caco-2 Cells; Cell Membrane Permeability; Crystallography, X-Ray; Fluorobenzenes; Humans; Mice; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Structure-Activity Relationship; Swine; Theophylline; Verapamil	2017
Comparative investigation of the influence of nizatidine, ranitidine, and cimetidine on the steady-state pharmacokinetics of theophylline in COPD patients. Journal of clinical pharmacology, 1992, Volume: 32, Issue:5 Topics: Administration, Oral; Aged; Cimetidine; Delayed-Action Preparations; Humans; Lung Diseases, Obstructive; Middle Aged; Nizatidine; Ranitidine; Theophylline	1992
Comment: Ranitidine does not inhibit theophylline metabolism. DICP : the annals of pharmacotherapy, 1991, Volume: 25, Issue:10 Topics: Biological Availability; Drug Interactions; Humans; Ranitidine; Theophylline	1991
[Effect of ranitidine on the pharmacokinetics of theophylline in patients with obstructive pulmonary disease]. Glas. Srpska akademija nauka i umetnosti. Odeljenje medicinskih nauka, 1991, Issue:41 Topics: Adult; Drug Therapy, Combination; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Ranitidine; Theophylline	1991
Lack of evidence for reduction of theophylline clearance by ranitidine. The American journal of medicine, 1989, Volume: 86, Issue:5 Topics: Cimetidine; Drug Interactions; Humans; Metabolic Clearance Rate; Ranitidine; Theophylline	1989
Theophylline toxicity subsequent to ranitidine administration: a possible drug-drug interaction. The American journal of medicine, 1989, Volume: 86, Issue:1 Topics: Adult; Child; Drug Interactions; Female; Humans; Male; Ranitidine; Theophylline	1989
Induction of theophylline toxicity and inhibition of clearance rates by ranitidine. The American journal of medicine, 1989, Volume: 86, Issue:4 Topics: Humans; Ranitidine; Theophylline	1989
[Theophylline poisoning caused by interaction with high-dose ranitidine]. Presse medicale (Paris, France : 1983), 1988, Feb-20, Volume: 17, Issue:6 Topics: Aged; Drug Interactions; Humans; Male; Ranitidine; Theophylline	1988
Induction of theophylline toxicity and inhibition of clearance rates by ranitidine. The American journal of medicine, 1988, Volume: 85, Issue:4 Topics: Aged; Female; Humans; Lung Diseases, Obstructive; Male; Metabolic Clearance Rate; Peptic Ulcer; Ranitidine; Theophylline	1988
Drugs in dentistry: Commonly prescribed medications, Part IV. Dental management, 1988, Volume: 28, Issue:8 Topics: Dental Care; Drug Therapy; Humans; Metoprolol; Nifedipine; Ranitidine; Theophylline; Thyroxine	1988
Combined administration of controlled release theophylline and ranitidine: a 53-day controlled survey in patients with chronic obstructive lung disease (COLD) and peptic disease. The British journal of clinical practice, 1987, Volume: 41, Issue:11 Topics: Aged; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Peptic Ulcer; Ranitidine; Theophylline	1987
Ranitidine at very large doses does not inhibit theophylline elimination. Clinical pharmacology and therapeutics, 1986, Volume: 39, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Chromatography, High Pressure Liquid; Cimetidine; Drug Interactions; Female; Humans; Kinetics; Male; Ranitidine; Theophylline	1986
[Changes in plasma levels of theophylline in therapeutic combination with cimetidine and ranitidine]. La Clinica terapeutica, 1986, Feb-28, Volume: 116, Issue:4 Topics: Adult; Asthma; Cimetidine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Peptic Ulcer; Ranitidine; Theophylline	1986
Repetitive oral activated charcoal and control of emesis in severe theophylline toxicity. Annals of internal medicine, 1986, Volume: 105, Issue:3 Topics: Administration, Oral; Adult; Charcoal; Droperidol; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Male; Ranitidine; Theophylline; Vomiting	1986
No evidence for interaction between ranitidine and theophylline. Archives of internal medicine, 1987, Volume: 147, Issue:1 Topics: Adolescent; Adult; Drug Interactions; Female; Humans; Male; Ranitidine; Theophylline	1987
Theophylline-ranitidine drug interaction in the beagle dog. Methods and findings in experimental and clinical pharmacology, 1985, Volume: 7, Issue:12 Topics: Animals; Dogs; Drug Interactions; Humans; Kinetics; Male; Ranitidine; Species Specificity; Theophylline	1985
Ranitidine and theophylline. Annals of internal medicine, 1985, Volume: 102, Issue:4 Topics: Aged; Drug Interactions; Female; Humans; Ranitidine; Theophylline	1985
Theophylline interaction with H2 receptor antagonists. Archives of internal medicine, 1984, Volume: 144, Issue:10 Topics: Humans; Ranitidine; Receptors, Histamine; Receptors, Histamine H2; Theophylline	1984
Effects of cimetidine and ranitidine on hepatic drug metabolism. Clinical pharmacology and therapeutics, 1982, Volume: 31, Issue:3 Topics: Adult; Antipyrine; Cimetidine; Drug Interactions; Female; Furans; Guanidines; Half-Life; Histamine H2 Antagonists; Humans; Liver; Male; Mixed Function Oxygenases; Ranitidine; Theophylline	1982
[Drug interferences with theophylline. Absence of interaction between theophylline and ranitidine]. La Nouvelle presse medicale, 1982, Nov-20, Volume: 11, Issue:47 Topics: Drug Interactions; Furans; Histamine H2 Antagonists; Humans; Ranitidine; Theophylline	1982
Ranitidine and theophylline. Annals of internal medicine, 1984, Volume: 100, Issue:3 Topics: Aged; Drug Interactions; Humans; Male; Ranitidine; Theophylline	1984
Inhibition of theophylline clearance by cimetidine but not ranitidine. Archives of internal medicine, 1984, Volume: 144, Issue:3 Topics: Adult; Cimetidine; Drug Interactions; Humans; Kinetics; Male; Random Allocation; Ranitidine; Theophylline	1984
Ranitidine and theophylline. Annals of internal medicine, 1984, Volume: 100, Issue:5 Topics: Aged; Antacids; Drug Interactions; Humans; Ranitidine; Theophylline	1984
Pharmacokinetics of theophylline and the H2-antagonist drugs cimetidine and ranitidine. International journal of clinical pharmacology, therapy, and toxicology, 1984, Volume: 22, Issue:4 Topics: Adult; Aged; Cimetidine; Dose-Response Relationship, Drug; Drug Interactions; Half-Life; Humans; Lung Diseases, Obstructive; Male; Metabolic Clearance Rate; Middle Aged; Ranitidine; Theophylline; Time Factors	1984
Antacids and theophylline-ranitidine interaction. Annals of internal medicine, 1984, Volume: 101, Issue:2 Topics: Antacids; Drug Interactions; Humans; Intestinal Absorption; Male; Ranitidine; Theophylline	1984
Drug interactions of H2-receptor antagonists. Scandinavian journal of gastroenterology. Supplement, 1994, Volume: 206 Topics: Adolescent; Adult; Aged; Antacids; Biological Availability; Cimetidine; Drug Interactions; Famotidine; Histamine H2 Antagonists; Humans; Middle Aged; Nizatidine; Omeprazole; Phenytoin; Ranitidine; Theophylline	1994
Theophylline-ranitidine interaction in elderly COPD patients. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 1995, Volume: 28, Issue:8 Topics: Age Factors; Aged; Drug Interactions; Drug Therapy, Combination; Histamine H2 Antagonists; Humans; Lung Diseases, Obstructive; Middle Aged; Ranitidine; Theophylline; Vasodilator Agents	1995
Evaluation of solid-state forms present in tablets by Raman spectroscopy. Journal of pharmaceutical sciences, 2000, Volume: 89, Issue:10 Topics: Anti-Inflammatory Agents; Anti-Ulcer Agents; Anticoagulants; Antihypertensive Agents; Bronchodilator Agents; Enalapril; Fourier Analysis; Prednisolone; Ranitidine; Spectrum Analysis, Raman; Tablets; Theophylline; Warfarin	2000
A tandem mass spectrometry assay for the simultaneous determination of acetaminophen, caffeine, phenytoin, ranitidine, and theophylline in small volume pediatric plasma specimens. Clinica chimica acta; international journal of clinical chemistry, 2008, Volume: 398, Issue:1-2 Topics: Acetaminophen; Analgesics; Anticonvulsants; Bronchodilator Agents; Caffeine; Calibration; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Histamine H2 Antagonists; Humans; Infant, Newborn; Phenytoin; Quality Control; Ranitidine; Reference Standards; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Theophylline	2008
Transmission electron microscopy of pharmaceutical materials. Journal of pharmaceutical sciences, 2010, Volume: 99, Issue:9 Topics: Acetaminophen; Caffeine; Crystallization; Microscopy, Electron, Transmission; Oxalic Acid; Pharmaceutical Preparations; Ranitidine; Theophylline	2010
Human in vivo regional intestinal permeability: quantitation using site-specific drug absorption data. Molecular pharmaceutics, 2015, Jun-01, Volume: 12, Issue:6 Topics: Budesonide; Colon; Cyclosporine; Fenofibrate; Humans; Intestinal Absorption; Intestinal Mucosa; Lisdexamfetamine Dimesylate; Metoprolol; Nifedipine; Pyrimidines; Ranitidine; Rivastigmine; Sumatriptan; Terfenadine; Theophylline	2015